For practitioners in humanitarian and development contexts
Women advancing the end of AIDS
Razum O et al. Covid-19 in Flüchtlingsunterkünften: ÖGD. Gesundheitswesen 2020; 82: 392–396
This report provides an overview of the key information gaps and limitations in interpreting existing COVID-19 data
CBR Advisory Working Group | Co-ordinator: Karen Heinicke-Motsch
Advocacy report March 2011
303100 03/2011 E 1,000
· Relevant interventions
· HIV country profiles
· Adolescents country profiles
Panam Salud Publica. 2021;45:e22. https://doi.org/10.26633/RPSP.2021.22
J Pharm Pharm Sci (www.cspsCanada.org) 16(3) 441 - 455, 2013
Virtual MentorAmerican Medical Association Journal of Ethics May 2007, Volume 9, Number 5:384-387
BUKO Pharma-Kampagne has investigated the causes and consequences of antibiotic resistance in India, South Africa, Tanzania and Germany. Together with our partners we collected data and did interviews with numerous stakeholders. The outcome is presented in a brochure that is now available in English...
Resistant bacteria are spreading worldwide. In collaboration with partners in India, Tanzania, South Africa and Germany, we have investigated the causes and consequences of this spread.2 This Pharma-Brief Special presents the results. It examines the risks for humans, animals and the environment. It focuses on local problems and approaches, international interactions and the re-sponsibility of doctors, farmers and consumers.
more